This inventor holds 2 USPTO granted patents. Top assignees: Enhance Pharmaceuticals, Inc., Purepac, Inc.. Active years: 1995-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2002
Title: The Innovative Contributions of John F. Cline
Introduction
John F. Cline is a notable inventor based in Westfield, NJ (US), recognized for his significant contributions to the field of controlled release devices. With a total of two patents to his name, Cline has made strides in the development of innovative methods that enhance drug delivery systems.
Latest Patents
Cline's latest patents include a method for injection molding manufacture of controlled release devices. This invention involves the production of thermoset polymer controlled release devices through the injection molding of two or more polymers in a mold, resulting in a core surrounded by a sheath. The polymers can be injected either sequentially or simultaneously. Another significant patent focuses on the transdermal administration of amines with minimal irritation. This patent describes an effective method for administering a skin irritating physiologically active amine in a minimally or nonirritating composition, which maintains a suitably high transdermal flux rate by utilizing a minimally or nonirritating salt of a fatty acid in a nonpolar, nonvolatile solvent.
Career Highlights
Throughout his career, John F. Cline has worked with several companies, including Enhance Pharmaceuticals, Inc. and Purepac, Inc. His work in these organizations has contributed to advancements in pharmaceutical technologies and drug delivery systems.
Collaborations
Cline has collaborated with notable coworkers such as Michelle McKenna and Angela Reid-Haqq, further enhancing the innovative environment in which he operates.
Conclusion
John F. Cline's contributions to the field of controlled release devices and drug delivery systems highlight his role as a significant inventor. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile